Pizza Business Delivers Record Growth as Stuffed Crust Sales and Discounts Drive Demand

The world's biggest pizza chain is on a roll, with strong sales growth at home and abroad. Innovative stuffed-crust products and well-timed discounts have proven a winning recipe for rising profits. Have you taken a bite?

Never Miss a Stock Recommendation Again!

We now send our dividend picks right to your phone via text, so you’ll get the same actionable moves without having to open your inbox.

👉 Click here to get our dividend picks by text and keep our content right at your fingertips.

Global Markets

The Wall Street Giant Finds Its Desert Gold in Saudi Arabia

JPMorgan Chase & Co. (NYSE: JPM) just secured its regional headquarters license in Saudi Arabia, a move that plugs the Wall Street titan directly into one of the fastest-growing financial hubs in the world.

The Riyadh base gives JPMorgan a front-row seat to deals tied to energy, infrastructure, and the region’s bold economic transformation.

You can see why this is a big deal if you follow how global finance is shifting eastward.

Saudi Arabia’s markets are opening fast, and having boots on the ground there means JPMorgan gets to write part of the next chapter in Middle Eastern banking.

The Kingdom’s Billion-Dollar Invitation

This expansion syncs perfectly with Saudi Arabia’s Vision 2030 program, which rewards companies that set up shop locally with access to lucrative government projects.

JPMorgan is answering that call, positioning itself as a partner in the kingdom’s modernization drive.

You might call it smart timing — the bank gets to build influence while others are still negotiating entry.

For a company already managing trillions globally, this is the kind of early move that builds long-term dominance.

The New Global Flow of Capital

While operations will still report to London, the Riyadh base signals a bigger trend in global banking strategy.

As Gulf nations invest heavily in diversification, money and influence are flowing into new centers of power.

If you’re tracking where opportunity is moving next, JPMorgan just drew you a map. The world’s financial pulse is expanding, and the rhythm now runs straight through Riyadh.

JPM currently trades at $310 and pays a dividend of $6.00 per share, a yield of 1.93%.

Retail

From Cart to Chat: The Retail Revolution Begins

Walmart Inc. (NYSE: WMT) just made online shopping a whole lot chattier by teaming up with OpenAI to let you buy products directly inside ChatGPT.

The new feature, called Instant Checkout, means you can ask for snacks, sneakers, or soap, and the AI will find it, price it, and let you check out without leaving the chat.

You might not realize it yet, but this could change how you think about e-commerce forever.

Walmart isn’t just following tech trends; it’s making them part of your everyday conversation.

From Aisles to Algorithms

This partnership is the next stage in Walmart’s seven-year AI experiment, where the company has quietly used algorithms to perfect logistics and personalize shopping.

Now, it’s turning that experience into something you can interact with in real time.

You can imagine the advantage of getting a personalized shopping assistant that never sleeps or misplaces your cart.

For Walmart, this isn’t just convenience; it’s data gold and a whole new way to connect with you.

Retail’s New Power Play

By blending AI with shopping, Walmart is rewriting what retail feels like in the digital age.

The brand that once defined big-box retail is now defining intelligent commerce that learns what you want before you do.

If you’re watching how AI moves from hype to habit, this is your proof in real time. Walmart isn’t just in your neighborhood anymore—it’s in your chat.

WMT currently trades at $109 and pays a dividend of $0.94 per share, a yield of 0.86%.

Time-Sensitive Report (Sponsored)

Final Call: 5 Stocks With Explosive Potential

Thousands of stocks were analyzed — only five made the cut.

This exclusive new report, “5 Stocks Set to Double,” highlights the companies that could be positioned for breakout growth as market trends shift heading into the new year.

Each one is backed by strong fundamentals and promising technical setups that could make early investors smile.

Past reports following this same system uncovered stocks that soared +175%, +498%, even +673%.

Download your free “5 Stocks Set to Double” report now before the clock hits midnight.

Your next big winner might be waiting inside.

*This free resource is being sent by Zacks. We identify investment resources you may choose to use in making your own decisions. Use of this resource is subject to the Zacks Terms of Service.
*Past performance is no guarantee of future results. Investing involves risk. This material does not constitute investment, legal, accounting, or tax advice. Zacks Investment Research is not a licensed dealer, broker, or investment adviser.

Pharma

The Pharma Power Player Quietly Transforming Its Future

AbbVie Inc. (NYSE: ABBV) is turning up the heat ahead of the European Society for Medical Oncology Congress in Berlin, revealing promising new data from its antibody-drug conjugate program.

The research targets some of the toughest cancers out there, like pancreatic and colorectal, with precision therapies designed to hit hard and minimize collateral damage.

You can feel the company’s confidence building as it moves deeper into oncology’s most competitive territory.

If you follow biopharma trends, you know this is the kind of shift that separates long-term innovators from one-hit wonders.

Betting on the Right Molecules

The new data doesn’t just highlight one promising therapy; it reinforces an entire platform that could redefine AbbVie’s future.

ADCs are where chemistry meets precision, and AbbVie wants to own that intersection as its next big growth engine.

You might see this as the company’s smartest hedge against fading blockbuster revenue.

With strong trial results stacking up, AbbVie is showing investors that it’s not waiting for the future—it’s engineering it.

The Bigger Picture for AbbVie

Oncology is now a cornerstone of AbbVie’s long-term strategy, joining its strongholds in neuroscience and immunology.

Multiple ADCs are advancing through late-stage trials, each one bringing the company closer to a new era of medical innovation.

If you’re watching where the next big pharma story unfolds, AbbVie just gave you a front-row ticket.

The company’s evolution isn’t just about drugs—it’s about defining the next phase of modern medicine.

ABBV currently trades at $227 and pays a dividend of $6.56 per share, a yield of 2.88%.

CFG has increased its dividend payment to 46 cents, a rise of 9.5%. Its new yield is 3.55%.

LBRT has boosted its dividend to 9 cents per share, an increase of 13%. Its new yield is 2.94%. 

AOS has lifted its dividend to 36 cents, a growth of 5.9%. Its new yield is 2.13%.

GLAD has reduced its dividend payment to 15 cents per share, a decline of 9.09%. Its new yield is 8.95%. 

BBD has dropped its dividend to 0.3 cents per share, a cut of 2.83%. Its new yield is 1.32%.

On The Radar (Sponsored)

These 7 Stocks Just Hit the Radar

Every month, we screen thousands of companies through our proprietary earnings-based ranking system.

The majority fail. Only a handful pass. And then, our analysts hand-select the best of the best.

This month, just 7 stocks made the cut — and we’re giving you their names for free.

With volatility at highs, this focused list could be the most important set of trades you make all year.

[Get your free copy of the 7 Best Stocks to Own Now.]

*This free resource is being sent by Zacks. We identify investment resources you may choose to use in making your own decisions. Use of this resource is subject to the Zacks Terms of Service.
*Past performance is no guarantee of future results. Investing involves risk. This material does not constitute investment, legal, accounting, or tax advice. Zacks Investment Research is not a licensed dealer, broker, or investment adviser.

Everything Else

• Walmart has teamed up with OpenAI to allow shoppers to buy products directly from ChatGPT.

• A new report authored by Cass Information Systems shows a freight market improvement for the month of September, driven primarily by an increase in truckload volumes across the sector.

• Meta has announced a significant change to its Teen Accounts, with the rollout of new protections guided by PG-13 movie ratings.  

• CVS has completed its purchase of customer prescriptions and health files from hundreds of closed Rite Aid drugstores and is now running 63 of the chain's locations.